SVX-32607-14318
2 vaccinations
4 coded responses
21 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 233 / VA
- Registered
- 2021-09-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-11
Dose 1 — Pfizer-BioNTech
-
2021-09-12
Registered in v-safe
-
2021-09-12
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-09-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness, Swelling · Muscle or body achesAdult check-in
- 2021-09-14
- 2021-09-15
- 2021-09-16
- 2021-09-17
- 2021-09-18
- 2021-09-25
-
2021-10-02
Dose 2 — Pfizer-BioNTech
-
2021-10-03
Survey response — days 1–6 daily, dose 2MedDRA: Gastrooesophageal reflux disease, Muscle spasms — Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Acid reflux/muscle spasmMedDRA releases: 2024-11 · check-in free text available
- 2021-10-04
-
2021-10-06
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness, Malaise — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Dizziness, MalaiseMedDRA releases: 2024-11 · check-in free text available
- 2021-10-07
- 2021-10-08
- 2021-10-09
-
2021-10-16
Survey response — day 14, dose 2MedDRA: Palpitations — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Heart palpitationsMedDRA releases: 2024-11 · check-in free text available
-
2021-10-16
Report sent to call center — day 14, dose 2Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2021-10-18
- 2021-10-23
- 2021-10-30
- 2021-11-06
- 2021-11-13
-
2022-01-01
Survey response — 3 months, dose 2MedDRA: Left ventricular dilatation, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Mild left ventricular dilation · Healthcare visit (other): Will be seeing cardiologistMedDRA releases: 2024-11 · check-in free text available
-
2022-01-01
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2022-01-05
Call successfulParticipant prefers to complete VAERS report online
- 2022-04-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-11 | Pfizer-BioNTech | No |
| 2 | 2021-10-02 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Acid reflux/muscle spasm
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness, Malaise
Release 10 — day 14, dose 2
Symptoms: Heart palpitations
Release 10 — 3 months, dose 2
Symptoms: Mild left ventricular dilation
Healthcare visit (other): Will be seeing cardiologist
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Left ventricular dilatation | · | · | ✓ |
| SD | Palpitations | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Gastrooesophageal reflux disease | · | · | ✓ |
| SRO | Malaise | · | · | ✓ |
| SRO | Muscle spasms | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release